Lactobacillus crispatus UALcr-35
- Reduced Candida Counts
- Improved Stability of Gut Microbiota
- Improved Symptoms of Bacterial Vaginosis
- Reduced Preterm Births
- Maintained Immune Homeostasis
- Increased Vaginal Lactobacillus Counts
- Increased IL-10 Production
- Reduced Total Side Effects Incidence
- Reduced Chlamydia trachomatis Infectivity
- Reduced Colitis Severity